Name: Latest research reports of J B Chemicals & Pharmaceuticals Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: J B Chemicals & Pharmaceuticals Ltd.
Rating: 4
Author: ICICI Securities Limited

J B Chemicals & Pharmaceuticals Ltd.

NSE: JBCHEPHARM | BSE: 506943 | ISIN: INE572A01036 | Industry: Pharmaceuticals
| Expensive Performer

1628.0000 36.50 (2.29%)

NSE Apr 16, 2025 15:31 PM

52W Low on Apr 07, 2025

Volume: 86,953

J B Chemicals & Pharmaceuticals Ltd.

08 Aug 2022

1628.00

2.29%

Strong performance

Accumulate: J B Chemicals & Pharmaceut...

Recommendation Target

ICICI Securities Limited

JB Chemicals & Pharmaceuticals (JBCPL) has reported a strong Q1FY23 performance, well ahead of our estimates, driven by robust growth in both domestic and CMO segments.

J B Chemicals & Phar.. has an average target of 1937.50 from 3 brokers.

The Baseline | 16 Apr 2025, 05:53PM

Market closes higher, Yes Bank receives a Rs 244.2 crore tax demand for AY16-17

Trendlyne Marketwatch | 16 Apr 2025, 04:04PM

New leadership, fresh strategy at JB Chemicals sees impact in Q1FY23

| 09 Sep 2022